Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Aldape

Showing results (181-190 of 345) with videos related to

Pageof 35
Sort By:
Pediatric Blood & Cancer|June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocolMary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
Cancer Research|May 8, 2007
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brainDiane Palmieri, Julie L Bronder, Jeanne M Herring, et al.
Autophagy|February 9, 2008
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3Hiroshi Aoki, Yasuko Kondo, Kenneth Aldape, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic MelanomaMichael A Davies, Katherine Stemke-Hale, E Lin, et al.
Neuro-Oncology|January 24, 2025
Metabolic profiling of meningioma reveals novel subgroup-specific biologic insights and outcome dependenciesAlexander P Landry, Justin Z Wang, Leeor S Yefet, et al.
Nature Medicine|May 2, 2022
A T cell resilience model associated with response to immunotherapy in multiple tumor typesYu Zhang, Trang Vu, Douglas C Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in MiceSun-Jin Kim, Ho Jeong Lee, Mark Seungwook Kim, et al.
Nature Medicine|August 11, 2022
Publisher Correction: A T cell resilience model associated with response to immunotherapy in multiple tumor typesYu Zhang, Trang Vu, Douglas C Palmer, et al.
The Journal of Clinical Investigation|December 14, 2011
Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patientsSameer Agnihotri, Aaron S Gajadhar, Christian Ternamian, et al.
Cancer Research|October 30, 2025
Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor HistopathologyDanh-Tai Hoang, Eldad D Shulman, Saugato Rahman Dhruba, et al.
Pageof 35

Showing results (181-190 of 345) with videos related to

Sort By:
Pageof 35
Pediatric Blood & Cancer|June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocolMary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
Cancer Research|May 8, 2007
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brainDiane Palmieri, Julie L Bronder, Jeanne M Herring, et al.
Autophagy|February 9, 2008
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3Hiroshi Aoki, Yasuko Kondo, Kenneth Aldape, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic MelanomaMichael A Davies, Katherine Stemke-Hale, E Lin, et al.
Neuro-Oncology|January 24, 2025
Metabolic profiling of meningioma reveals novel subgroup-specific biologic insights and outcome dependenciesAlexander P Landry, Justin Z Wang, Leeor S Yefet, et al.
Nature Medicine|May 2, 2022
A T cell resilience model associated with response to immunotherapy in multiple tumor typesYu Zhang, Trang Vu, Douglas C Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in MiceSun-Jin Kim, Ho Jeong Lee, Mark Seungwook Kim, et al.
Nature Medicine|August 11, 2022
Publisher Correction: A T cell resilience model associated with response to immunotherapy in multiple tumor typesYu Zhang, Trang Vu, Douglas C Palmer, et al.
The Journal of Clinical Investigation|December 14, 2011
Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patientsSameer Agnihotri, Aaron S Gajadhar, Christian Ternamian, et al.
Cancer Research|October 30, 2025
Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor HistopathologyDanh-Tai Hoang, Eldad D Shulman, Saugato Rahman Dhruba, et al.
Pageof 35